ÂÜÀòÂÒÂ×

Andi Stratton is a seasoned professional in the field of national accounts, currently serving as the Director of National Accounts at Krystal Biotech, Inc. since May 2022. Stratton has extensive experience in the biopharmaceutical industry, having held similar director-level positions at Astellas Gene Therapies, Novartis Gene Therapies, and AveXis, Inc. Prior roles include Regional Account Executive at Amgen and Regional Account Manager at Biogen, where responsibilities encompassed market access and reimbursement. Stratton's career began at Pfizer, where achievements included ranking as a top salesperson and receiving multiple awards for outstanding performance. Stratton holds a degree from Luther College.